A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Condition(s):Cardiogenic ShockLast Updated:October 13, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Cardiogenic ShockLast Updated:October 13, 2023Not yet recruiting
Condition(s):COVID-19; Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Last Updated:June 23, 2023Completed
Condition(s):Cardiogenic ShockLast Updated:August 14, 2023Active, not recruiting
Condition(s):Respiratory Distress Syndrome, NewbornLast Updated:May 24, 2023Terminated
Condition(s):HypertensionLast Updated:February 21, 2023Completed
Condition(s):Respiratory Distress SyndromeLast Updated:April 23, 2021Completed
Condition(s):Acute Decompensated Heart FailureLast Updated:May 24, 2023Completed
Condition(s):Respiratory Distress SyndromeLast Updated:July 23, 2019Terminated
Condition(s):Respiratory Distress SyndromeLast Updated:April 21, 2017Completed
Condition(s):Respiratory Distress SyndromeLast Updated:June 13, 2012Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.